-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SIFH6TJ6495Nrh7IxfelWEVeBSO/x5p1ibYbFq77Lrv6wtGXjrF4QcpZN3U9S46n GkgOpemBGPWrYOusuF1lRA== 0000352747-10-000003.txt : 20100329 0000352747-10-000003.hdr.sgml : 20100329 20100329150729 ACCESSION NUMBER: 0000352747-10-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100329 DATE AS OF CHANGE: 20100329 EFFECTIVENESS DATE: 20100329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIGENE LABORATORIES INC CENTRAL INDEX KEY: 0000352747 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 222328609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-35274-7N FILM NUMBER: 10710464 BUSINESS ADDRESS: STREET 1: 81 FULTON STREET CITY: BOONTON STATE: NJ ZIP: 07005 BUSINESS PHONE: 973-265-1100 MAIL ADDRESS: STREET 1: 81 FULTON STREET CITY: BOONTON STATE: NJ ZIP: 07005 D 1 primary_doc.xml X0603 D LIVE 0000352747 UNIGENE LABORATORIES INC 81 FULTON STREET BOONTON NJ 07005 973-265-1100 DELAWARE None None Corporation true Zvi Eiref 81 Fulton Street Boonton NJ 07005 Director Marvin Miller 81 Fulton Street Boonton NJ 07005 Director Bruce Morra 81 Fulton Street Boonton NJ 07005 Director Peter Slusser 81 Fulton Street Boonton NJ 07005 Director Ronald S. Levy 81 Fulton Street Boonton NJ 07005 Executive Officer Richard Levy 81 Fulton Street Boonton NJ 07005 Director Chairman of the Board. J. Thomas August 81 Fulton Street Boonton NJ 07005 Director Allen Bloom 81 Fulton Street Boonton NJ 07005 Director James P. Gilligan 81 Fulton Street Boonton NJ 07005 Executive Officer Nozer M. Mehta 81 Fulton Street Boonton NJ 07005 Executive Officer Paul P. Shields 81 Fulton Street Boonton NJ 07005 Executive Officer William Steinhauer 81 Fulton Street Boonton NJ 07005 Executive Officer Biotechnology $5,000,001 - $25,000,000 06 false 2010-03-17 true true true Issuance of senior secured convertible notes convertible into shares of Unigene's common stock, under certain circumstances. Full conversion is subject to Unigene amending its charter to increase the number of shares which Unigene is authorized to issue. false 0 RBC Capital Markets Corporation 31194 None None Three World Financial Center 200 Vesey Street New York NY 10281-8098 IL 36000000 33000000 3000000 Consideration for issuance of the senior secured convertible notes on March 17, 2010 consisted of surrender of existing senior secured non-convertible term notes in the principal amount of $19,357,528 and the balance in cash. false 1 464274 0 Sales commissions includes $55,000 of out-of-pocket and legal expenses. 0 false UNIGENE LABORATORIES INC /s/ Warren P. Levy Warren P. Levy President and Chief Executive Officer 2010-03-29 -----END PRIVACY-ENHANCED MESSAGE-----